Enterprise Value Chart

View Enterprise Value for PAIOF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Enterprise Value Data

View and export this data back to 2005. Start Trial.
Date Value
September 18, 2026 -35.00M
September 17, 2026 -35.00M
September 16, 2026 -35.00M
September 15, 2026 -35.00M
September 14, 2026 -35.00M
September 11, 2026 -35.00M
September 10, 2026 -35.00M
September 09, 2026 -35.00M
September 08, 2026 -35.00M
September 04, 2026 -35.00M
September 03, 2026 -35.00M
September 02, 2026 -35.00M
September 01, 2026 -35.00M
August 31, 2026 -35.00M
August 28, 2026 -35.00M
August 27, 2026 -35.00M
August 26, 2026 -35.00M
August 25, 2026 -35.00M
August 24, 2026 -35.00M
August 21, 2026 -35.00M
August 20, 2026 -35.00M
August 19, 2026 -35.00M
August 18, 2026 -35.00M
August 17, 2026 -35.00M
August 14, 2026 -35.00M
Date Value
August 13, 2026 -35.00M
August 12, 2026 -35.00M
August 11, 2026 -35.00M
August 10, 2026 -35.00M
August 07, 2026 -35.00M
August 06, 2026 -35.00M
August 05, 2026 -35.00M
August 04, 2026 -35.00M
August 03, 2026 -35.00M
July 31, 2026 -35.00M
July 30, 2026 -35.00M
July 29, 2026 -35.00M
July 28, 2026 -35.00M
July 27, 2026 -35.00M
July 24, 2026 -35.00M
July 23, 2026 -35.00M
July 22, 2026 -35.00M
July 21, 2026 -35.00M
July 20, 2026 -35.00M
July 17, 2026 -35.00M
July 16, 2026 -35.00M
July 15, 2026 -35.43M
July 14, 2026 -35.43M
July 13, 2026 -35.43M
July 10, 2026 -35.43M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
CureVac NV --
Anbio Biotechnology --
Epigenomics AG -2.521M
ACADIA Pharmaceuticals, Inc. 3.815B
Alkermes Plc 8.186B